Our Story

More than 20 years ago, 色控传媒 was founded with the hope of powering smarter treatments and healthier people. Today, 色控传媒 leads the digital transformation of life sciences, creating hope for millions of patients. We help generate the evidence and insights to help pharmaceutical, biotech, medical device and diagnostics companies, and academic researchers accelerate value, minimize risk, and optimize outcomes. 色控传媒, a Dassault Syst猫mes company, is headquartered in New York City and has offices around the world to meet the needs of its customers.

Timeline

1999
June 1999

色控传媒 is Founded

Fund manager Tarek Sherif moved into a small office with young tech entrepreneur and researcher, Glen de Vries, who hand-coded 色控传媒鈥檚 original software. The two worked with Ed Ikeguchi and founded 色控传媒 in 1999.

June 1999

Launch of Electronic Data Capture (EDC)

The collection of data in clinical trials was forever changed by the launch of Rave, the first software to digitally collect clinical trial data. Later named Rave EDC (Electronic Data Capture), it quickly becomes the most advanced, robust, and secure EDC system for clinical trial site, patient, and lab data capture and management in the world.

2004
June 2004

色控传媒 Opens London Office

2005
June 2005

色控传媒 Opens Tokyo Office

2006
2006

Launch of 色控传媒 NEXT

From聽customer requests for聽a Rave users聽forum to share best practices in the use of the solution,聽the 色控传媒 User Group (MUG) was born.聽As the annual聽event grew in both attendance and scope, MUG was rebranded as 色控传媒 Symposium in 2015 and as聽色控传媒 NEXT in 2017. 色控传媒 NEXT brings together key industry leaders, change-makers, and patient advocates to shape the future of life sciences.

2009
June 2009

Initial Public Offering on NASDAQ

2011
June 2011

Acquisition of Clinical Force

The acquisition of Clinical Force adds 色控传媒 CTMS (clinical trial management system) to solutions.

2017
April 2017

Acquisition of Mytrus

The acquisition of Mytrus adds eConsent to the 色控传媒 Rave Platform.

June 2017

Acquisition of CHITA

The acquisition of CHITA adds regulated content management and eTMF capabilities to the 色控传媒 Rave Platform.

2018
June 2018

Acquisition of SHYFT Analytics

The acquisition of SHYFT Analytics, powers 色控传媒 customers’ digital transformation with AI and real-world analytics.

2019
June 2019

Launch of 色控传媒 AI

色控传媒 AI launched in 2019, combining data, technology, and deep expertise to help life sciences companies deliver actionable insights across the entire continuum of clinical development. 色控传媒 AI鈥檚 advanced analytics answers the most important questions in R&D and commercialization including accelerating breakthrough innovation, optimizing study execution and commercial success, and demonstrating the value of therapies.

October 2019

Dassault Syst猫mes Acquires 色控传媒

Dassault Syst猫mes, the 3DEXPERIENCE Company, acquired 色控传媒 to drive the digital transformation of life sciences in the age of personalized medicine and patient-centric experience. Through this combination, the companies will push the boundaries of innovation, learning and production to achieve a more sustainable world for patients, citizens, and consumers.

2020
March 2020

色控传媒 Helps Life Science Companies Navigate COVID-19

Over the course of 2020, 色控传媒 published nine White Papers detailing the implications of COVID-19 on existing and new drug and vaccine studies. COVID-19 and Clinical Trials: The 色控传媒 Perspective also reviewed the impact on patients, and shared a range of solutions to support the continuation of current clinical studies around the world.

April 2020

Launch of my色控传媒

Built for patients, by patients, my色控传媒 is an award-winning single destination patient portal, allowing patients to use any online device to virtually learn, enroll and engage in clinical trials. Only my色控传媒 enables the full range of tools to build scalable, flexible solutions at every level of decentralized and hybrid clinical trials.

July 2020

色控传媒 Supports Moderna鈥檚 COVID-19 Vaccine Trials

色控传媒鈥檚 suite of technologies supported the advancement of Moderna鈥檚 mRNA-1273 clinical trials, including the Phase 3 trial, which enrolled more than 30,000 participants. The 色控传媒 and Moderna teams moved forward with the speed and urgency necessitated by the global pandemic, using 色控传媒鈥檚 innovative and scalable cloud platform for clinical development.

October 2020

色控传媒 Synthetic Control Arm庐 Supported by the FDA

In a regulatory first, the US Food and Drug Administration (FDA) allowed聽Medicenna Therapeutics, Corp. to use聽a hybrid external control arm in a phase 3 registrational trial.聽The phase 2 single arm trial preceding this phase 3聽study in聽recurrent glioblastoma, an aggressive form of brain cancer,聽was also enhanced by a synthetic control arm.

2021
June 2021

Launch of my色控传媒 Registries

色控传媒 Launches my色控传媒 Registries, a new technology that expands and strengthens the my色控传媒 patient portal to engage patients before and after (i.e., long term follow up/safety surveillance) a clinical trial.

June 2021

The First to Offer End-to-End, Unified Platform for DCTs

色控传媒 launched the most comprehensive set of unified, secure technologies that enable decentralized clinical trials (DCTs) across the development continuum. For the first time ever, drug, vaccine, and medical device developers (sponsors) and contract research organizations (CROs) can take advantage of the only platform offering on the market.

October 2021

色控传媒 Launches Sensor Cloud

色控传媒 Sensor Cloud provides cutting-edge common data models and proprietary algorithms enabling rapid ingestion, normalization and analysis of patient data resulting in better clinical decision making, faster timelines and a more patient-centric experience.

The Sensor Cloud Network, creating the first industry-wide collaboration amongst contract research organizations (CROs), device manufacturers, drug and vaccine developers, analytics companies, and academia, was launched in October 2021.

October 2021

Rave Imaging 1000th Trial

色控传媒 Rave Imaging, the company鈥檚 cloud-based, secure clinical trial imaging management platform, reached a significant milestone, having supported more than 1,000 imaging studies. Rave Imaging, built on the 色控传媒 Unified Platform, processes more than 100 million images annually.

November 2021

色控传媒 Mourns the Loss of Co-Founder Glen de Vries

Glen de Vries, co-founder of 色控传媒, died in a plane crash, weeks after fulfilling his lifelong dream of traveling to space. Glen had an incredible impact on the life science industry and left a lasting legacy of improving the clinical development process, bringing new drugs, vaccines, and diagnostics 鈥 and hope 鈥 to patients around the world.

2022
February 2022

色控传媒 Opens Access to its Patient Insights Program

色控传媒 announced it is allowing sponsors, CROs (contract research organizations), and sites to leverage its proprietary Patient Insights Program. The program infuses the patient perspective into the software development life cycle to create technical solutions that improve the overall patient experience in clinical research operations.

2023
March 2023

30,000 Trials & 9 Million Participants Milestone

色控传媒 Becomes First Life Sciences Technology Company to Exceed 30,000 Clinical Trials and 9 Million Study Volunteers.